.png)
We are a Team of Award-Winning Scientists Creating a World with Healthier Microbiomes
Our platform is the result of our team’s combined expertise in genetics, epigenetics, and microbiome research.
We utilise deep molecular analysis and next-generation sequencing (NGS) technology to understand the impact of product usage on an individual’s microbiome.Through our efforts, we hope to revolutionise the way in which the industry develops and tests its products to deliver optimal results to those utilising them.
Our Mission
Sequential is the industry leader in clinical microbiome research and testing offering a comprehensive end-to-end platform designed to bring science-backed solutions to the personal care and pharmaceutical industry. Our mission is to understand the impact of the microbiome on the host (humans) and how the host impacts the microbiome in order to characterise human health fully.
We offer an extensive platform to conduct research on personal care products through microbiome testing, and biophysical assessments, and offer full recruitment services for studies. We are keen to publish our findings with our partners to increase the literature within this space. At present our database of over 20,000 human microbiome samples is one of the most sophisticated within the industry and is growing rapidly.
%20(1).png)
Innovation
Pioneering the forefront of biological science, we consistently introduce groundbreaking advancements to redefine industry standards.
Transparency
Our commitment to openness ensures a clear understanding of our human microbiome testing processes and analysis.
Reliability
We guarantee dependable results, fostering trust in the accuracy of our analyses.
Scientific Board of Advisors
Our advisors are world leaders in the skin microbiome and have extensive experience in bringing forward solutions for skin concerns
Prof. Tom Dawson
Senior Principal Investigator at Skin Research Institute of Singapore. Over 30 years experience in biotechnology innovations, and expert in the skin and hair microbiome. Doctor of Philosophy (PhD), Pharmacology at the University of North Carolina.
Prof. Phillip Bennett
Phillip Bennett is Professor of Obstetrics and Gynaecology and Director of the Institute of Reproductive and Developmental Biology. Professor Bennett has been one of the key pioneers in researching the vaginal microbiome. In particular, to understand and characterise the impact of the vaginal microbiome on preterm labour. Bennett has published over 400 peer-reviewed research articles over his career.
Dr Kimberly Capone
Dr Kimberly Capone is a pioneer and established expert in microbiology and the human microbiome field where she created new business opportunities across multiple brands over 13 years at Johnson & Johnson Consumer, Inc. Areas of concentration included infant and adult skin, vaginal, gut, and oral health.
Dr Natalya Fox
Dr Natalya Fox is a Dermatologist at the NHS - St George's Hospital, London. Previously, Fox did her MBChB at the University of Edinburgh 2014 and has her Full MRCP UK in Dermatology. Fox is passionate about the skin microbiome and its place in dermatology.
Prof Eran Segal
Eran Segal is a Professor at the Department of Computer Science and Applied Mathematics at the Weizmann Institute of Science. His group has extensive experience in machine learning, computational biology, and analysis of heterogeneous high-throughput genomic data.
Prof. Niranjan Nagarajan
Associate Director & Senior Group Leader at Genome Institute of Singapore. Expert in computation biology, in particular the study of microbial communities resident on the human skin. Doctor of Philosophy (PhD), Computer Science at Cornell University.
Dr Alexander Lezhava
Senior Group Leader & Associate Director at Genome Institute of Singapore. Expert in the commercial development of medical diagnostics and clinical-grade molecular assays. Doctor of Philosophy (PhD), Microbiology at Hiroshima University.
Prof. Elena Lurie-Luke
A senior R&D, Innovation and Entrepreneurship Executive with extensive technical, strategic business development. Proven leadership experience in both global FMCG and public health sector environments.
Please find listed a selection of relevant peer-reviewed publications from our advisors.
-
Wu G, TL Dawson, et al. (2015) Genus-Wide Comparative Genomics of Malassezia Delineates Its Phylogeny, Physiology, and Niche Adaptation on Human Skin. PLOS Genetics 11(11): e1005614.
-
Chng, K., Nagarajan, N., et al. (2016) Whole metagenome profiling reveals skin microbiome-dependent susceptibility to atopic dermatitis flare. Nat Microbiol 1, 16106.
-
Tay, A.S., Nagarajan, N., et al (2018). 1039 Skin microbiome profiles of atopic dermatitis patients segregate into two community composition types that are stable before and after therapy. Journal of Investigative Dermatology. 138. S176. 10.1016/j.jid.2018.03.1051.
-
Ramasamy S., Barnard, E., Dawson, TL, and Huiying Li. (2019). Role of the skin microbiota in acne pathophysiology. British Journal of Dermatology, https://doi.org/10.1111/bjd.18230.
-
Dawson, TL. (2019) Malassezia: The Forbidden Kingdom Opens. Cell Host Microbe https://doi.org/10.1016/j.chom.2019.02.010
-
Tay, A.S., Nagarajan, N., et al (2020). Atopic dermatitis microbiomes stratify into ecologic dermotypes enabling microbial virulence and disease severity. The Journal of allergy and clinical immunology. 10.1016/j.jaci.2020.09.031.
-
Dawson, TL. (2021) Malassezia: A Skin Commensal Yeast Impacting Both Health and Disease. Front. Cell. Infect. Microbiol., doi.org/10.3389/fcimb.2021.659219
Supported By
Our Team at Sequential
Dr. Oliver Worsley
CEO & CO-FOUNDER
Oliver is the co-founder and CEO of Sequential. He completed his PhD in molecular genetics as a scholar at the Genome Institute of Singapore from 2014-2018, and has won multiple awards including the P&G Young Entrepreneurship Scheme, presented at the Royal Society in London in 2017; and the top prize at the L’Oréal Innovation Runway 2018. Oliver has previously founded Anya Consulting, a healthcare communications company that has published >150 articles and has produced several technical whitepapers for clients like Fierce Health. Prior, Oliver completed his BSc at Edinburgh University, including six months at Leiden University Medical Centre through the Erasmus Programme.
Sibora Peca
US OPERATIONS MANAGER
Emma Gray
STRATEGIC PARTNERSHIPS
Melissa Ople
ADMINISTRATIVE ASSISTANT
Grace Francis
ADMINISTRATIVE ASSISTANT
Dr. Albert Dashi
CHIEF SCIENCE OFFICER & CO-FOUNDER
Albert is the co-founder and CSO of Sequential. He completed his PhD in molecular genetics, epigenetics and stem cell research at the National University of Singapore (NUS) and the Genome Institute of Singapore in 2019. In 2014, he received the Singapore International Graduate Award from A*STAR for his PhD research and was also awarded the “Young Investigator” award. He also won the “Young Entrepreneur Scheme” award by P&G for his innovative and business driven ideas. Prior moving to Singapore for his doctor program, Albert obtained his Masters in Biomedical Sciences at University of Bern, Switzerland.
Andrew Davis
SENIOR BIOINFORMATICIAN
Forest Wong
SENIOR LAB TECHNICIAN
Alena Romanova
RESEARCH ASSOCIATE
Petronille Houdart, PharmD
SKINCARE DIRECTOR
Petronille is Sequential's lead skincare director, focused on translating the latest in skin science to personalised skincare recommendations. She has over a decade in the industry, working with international brands to lead and consult on R&D, creative projects and brand innovation. Petronille also led her own award-winning dermocosmetic brand, Petronille Dermo Cosmetic, that produced customisable products for men and women. Petronille holds an MSc in Cosmetology Sciences and a professional doctorate in pharmacy (specialising in dermo-pharmacy) from Paris Descartes University.
Marya Sheikh-Ahmed
SENIOR MARKETING ASSOCIATE
Lina Benjelloun
RESEARCH ASSOCIATE
Dr. Sija Sajibu
RESEARCH ASSOCIATE
Kinza Mahmood
RESEARCH ASSISTANT
Our Labs
Sequential has microbiome testing labs in New York City, London and Singapore. Being close to our customers has allowed us to reduce turnaround time, whilst retaining the intellectual property in-house.
Proud to Have Worked With
